Paris Transplant Group at ASN 2019

GET ON BOARD FOR AN EXCITING JOURNEY:
LET THE IBOX ALGORITHM TAKE YOU TO THE NEXT LEVEL​

At the ASN Kidney Week, the Paris Transplant Group presents the iBox. You can participate in the development of new functionalities and potential new applications for the iBox in transplant centers or as a tool for clinical trials. Feel free to ask for collaboration opportunities.

Ask for collaboration opportunities

Presentations of the Paris Transplant Group at ASN 2019

Alexandre Loupy

Thu 7 - Starting at 4:42 PM, Room 151

“Absence of Additional Predictive Ability Value of Preimplantation Biopsies for Long-Term Allograft Outcome”
Read abstract 

Fri 8 -  Starting at 10:00 AM, Exhibit hall

“Transplantation : Clinical-Immunosuppression, Adherence, Outcomes”

Fri 8 -  Starting at 2:30 PM, Room 201

“An Integrated Prediction Score of Allograft Survival”

Carmen Lefaucheur

Fri 8 -  Starting at 3:00 PM, Room 201

“Gene Expression Profiling and Histologic and Noninvasive Biomarkers in Antibody-Mediated Rejection”

​Follow the event on Twitter 
with the hashtag #KidneyWk and follow us @ParisTxGroup

Takeaway from ASN 2019

iBox: Prediction system 
for risk of kidney allograft loss

Based on data easily available during patient follow-up after a kidney transplant, the tool generates probabilities of graft loss up to 10 years after patient evaluation. Tested on more than 7,500 patients, the predictions of this tool are highly reliable regardless of the health system, the clinical situation, the therapeutic intervention or the treatment of the patient.

Read more about the iBox

---

For clinicians

The iBox, an integrative, accurate, and readily implementable risk prediction score for kidney allograft failure, has been developed and shows generalisability across centres worldwide and common clinical scenarios. 

For clinical trials

The iBox risk prediction score may help to guide the monitoring of patients and further improve the design and development of a valid and early surrogate endpoint for clinical trials.

⏯ Use case: the TRANSFORM study

ASN 2019: time to take action

BE PART OF THE EFFORT TO PROVIDE TRANSPLANT PATIENTS
​WITH PERSONALIZED AND PROGNOSTIC MEDICINE WITH THE IBOX